Turn to some domestic news. China has given the green light to imported new drugs. The China Food and Drug Administration says it has further simplified the examination and approval procedures for imported drugs. Under the reform measures, new drugs for rare and fatal diseases are able to directly submit their research filings overseas to the Chinese drug authorities for a quick pass. Since mid-April, China has been given passes to seven imported drugs including the much-anticipated nine-valent HPV Vaccine. But at the same time, the supervision and review measures will be strengthened to guarantee drugs' safety after they enter the Chinese market. The move just follows China's recent removal of imported drug tariffs on all cancer drugs on May 1st. 

JIAO HONG, HEAD CHINA FOOD AND DRUG ADMINISTRATION "Based on our scientific reviews and simplified procedures, we have sped up the examination of new drugs for rare diseases as well as those most needed in clinics including anti-AIDs and anti-tumour drugs. In this way, these new drugs are expected to enter the Chinese market one or two years in advance."